AN ASSESSMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE ELIGIBLE FOR FIRST-LINE THERAPY BUT UNSUITABLE FOR FULL-DOSE FLUDARABINE.

EHA Library, Dusha Jeyakumaran, 134690

INSULIN-LIKE GROWTH FACTOR SYSTEM AS A PROGNOSTIC BIOMARKER IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CROSS-SECTIONAL STUDY

EHA Library, Antigoni Lekka, 134691

SECONDARY MALIGNANCIES IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

EHA Library, Gianluigi Reda, 134692

COMPLEX ACTIVATION OF ANGIOGENIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CIRCULATING ANGIOGENIC CYTOKINES.

EHA Library, Lukáš Smolej, 134693

FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL)

EHA Library, Andrew Pettitt, 134694

SERUM RESISTIN IN RELATION TO B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA RISK AND ITS CORRELATIONS WITH PROGNOSTIC BIOMARKERS

EHA Library, Antigoni Lekka, 134695

CALRETICULIN GENE MUTATION IN HAIRY CELL LEUKEMIA AND RELATIONSHIP WITH PROGNOSIS

EHA Library, Salih Subari, 134696

FACTORS ASSOCIATED WITH TREATMENT CHOICE AND RESPONSE IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RE-TREATED WITH RITUXIMAB: THE OBSERVATIONAL PERLE STUDY

EHA Library, Driss Chaoui, 134697

PLATELET DYSFUNCTION CAUSED BY IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. MONOCENTRIC EXPERIENCE: CLINICAL AND LABORATORY CHARACTERIZATION.

EHA Library, Idanna Innocenti, 134698

EFFICACY OF IBRUTINIB-BASED THERAPY IN THE TREATMENT OF RECURRENT AND REFRACTORY FORMS OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aleksei Kuvshinov, 134699

USE OF IBRUTINIB IN PATIENTS WITH B CELL LYMPHOID MALIGNANCIES: ADVERSE EVENTS AND MANAGEMENT IN COMMUNITY SETTING

EHA Library, Rajeev Ramakrishna, 134700

APPLYING PROBED CAPILLARY ISOELECTRIC FOCUSING (PROBED CIEF) FOR RESPONSE MONITORING OF SIGNAL INHIBITOR THERAPY DIRECTED AGAINST BRUTONS TYROSINE KINASE (BTK) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, John Burthem, 134701

IS C-REACTIVE PROTEIN A RELIABLE SURROGATE MARKER FOR INFECTION TO HELP FACILITATE DISCHARGE IN PATIENTS ON IBRUTINIB? (A SINGLE CENTRE EXPERIENCE)

EHA Library, David Sparksman, 134702

DYNAMICS OF BCR-ABL1 MULTIPLE MUTATION DETECTED BY SUBCLONING AND SEQUENCING IN TYROSINE KINASE INHIBITOR RESISTANT CML

EHA Library, Ki Hoon Kang, 134703

PPAR? IS A NOVEL THERAPEUTIC TARGETS IN PH-POSITIVE LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 134704

PLASMA PROTEOMICS IN CHRONIC MYELOID LEUKEMIA PATIENTS BEFORE AND AFTER INITIATION OF TYROSINE KINASE INHIBITOR THERAPY REVEALS INDUCED TH1 IMMUNITY AND LOSS OF ANGIOGENIC STIMULI

EHA Library, Stina Söderlund, 134705

LEUKEMIC STEM CELLS DEFINED BY DIPEPTIDIL-PEPTIDASE IV (CD26) EXPRESSION IN CD34+CD38- STEM CELLS AND TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA

EHA Library, Paulo Rodrigues-Santos, 134706

MODULATION OF LEUKOTRIENE SIGNALING INHIBITING CELL GROWTH IN CHRONIC MYELOID LEUKEMIA

EHA Library, Elham Yektaei-Karin, 134707

ISODERIVATIVE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Anna Lukyanova, 134708

MOLECULAR AND FUNCTIONAL INTEGRITY OF CRYOPRESERVED CHRONIC MYELOID LEUKAEMIA CD34-POSITIVE HAEMATOPOIETIC STEM CELLS

EHA Library, Clare Hodkinson, 134709

COMBINED ANTICANCER ACTIVITY AND SIRNA DELIVERY BY DENGUE VIRUS CAPSID PROTEIN PEPTIDES PEPR AND PEPM AGAINST CHRONIC MYELOID LEUKEMIA

EHA Library, Ines Figueiredo, 134710

ASSOCIATION OF 3?BCR GENE DELETION WITH LACK OF MOLECULAR RESPONSE IN CML PATIENTS WITH PH-VARIANTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Branimir Spassov, 134711

PROTEOMIC PROFILE CORRELATES TO MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Nicola Sgherza, 134712

EVALUATION OF BECLIN-1 PROTEIN EXPRESSION IN CHRONIC MYELOID LEUKEMIA PATIENTS ON IMATINIB THERAPY

EHA Library, Ziad Emarah, 134713

REVERSINE TRIGGERS MITOTIC CATASTROPHE AND APOPTOSIS IN BCR-ABL POSITIVE CELLS

EHA Library, Ana Alves, 134714

COMPARISON BETWEEN AUTOMATED AND MANUAL INTERPHASE FLUORESCENT IN SITU HYBRIDIZATION (FISH) ANALYSIS OF T(9;22)(Q43;Q11.2)

EHA Library, Hend Chaker, 134715

HALVING TIME AND LOG REDUCTION ARE GOOD PREDICTORS OF OPTIMAL MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH SUB-OPTIMAL RESPONSE AT 3 MONTHS

EHA Library, Maria João Santos, 134716

EVALUATION OF CLINICAL EFFICACY AND SAFETY OF GENERIC IMATINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

EHA Library, Cojbasic Irena, 134717

PREDICTIVE FACTORS OF STABLE DEEP MOLECULAR RESPONSE IN CHRONIC PHASE CML PATIENTS TREATED WITH DASATINIB OR NILOTINIB AFTER IMATINIB FAILURE

EHA Library, Massimiliano Bonifacio, 134718

MTOR INHIBITION IN CML: A NEW THERAPEUTIC OPTION

EHA Library, Ana Bela Sarmento-Ribeiro, 134719

EFFICACY AND SAFETY EVALUATION OF NILOTINIB AND DASATINIB (2G-TKI) ON FIRST LINE TREATMENT IN 73 PATIENTS WITH CML-CP OUTSIDE OF CLINICAL TRIALS. ANDALUSIAN CML REGISTRY (RALMC).

EHA Library, José Manuel Puerta Puerta, 134720

OPTIMIZATION OF RADOTINIB DOSES BASED ON DOSE-EFFICACY AS WELL AS DOSE-SAFETY RELATIONSHIP ANALYSES FOR NEWLY DIAGNOSED PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Hayeon Noh, 134721

REAL-WORLD DATA FROM 54 BELGIAN PATIENTS FROM THE PONATINIB NAMED PATIENT PROGRAMME (NPP)

EHA Library, Timothy Devos, 134722

PREDICTORS FOR 12-MONTH MAJOR MOLECULAR RESPONSE IN CP CML PATIENTS WHO FAILED 3-MONTH EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY

EHA Library, Sung-Eun Lee, 134723

REAL-WORLD TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS WHO FAILED ≥2 PRIOR TYROSINE KINASE INHIBITORS (TKIS) AMONG US COMMUNITY ONCOLOGISTS

EHA Library, Huiqiang Huang, 134724

STEPWISE DOSE ESCALATION METHOD FOR NILOTINIB STOP TRIAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (STEP STOP TRIAL) : A MULTICENTER PHASE 2 TRIAL

EHA Library, Ken Ota, 134725

IMMUNOMODULATORY EFFECT OF DASATINIB THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Maria Cioch, 134726

2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS

EHA Library, Massimo Breccia, 134727

COMBINATION OF HEMOGLOBIN LEVEL AT PRESENTATION WITH MOLECULAR RESPONSE AT 3 MONTHS BETTER PREDICTS SURVIVALS AND DEEP MOLECULAR RESPONSE TO IMATINIB IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Po-Shen Ko, 134728

TREATMENT, RESPONSE, AND OUTCOME IN UNSELECTED ELDERLY PATIENTS WITH NEWLY DIAGNOSED, CHRONIC PHASE (CP), PHILADELPHIA CHROMOSOME-POSITIVE (PH+) CHRONIC MYELOID LEUKEMIA

EHA Library, Gabriele Gugliotta, 134729

THYROID DYSFUNCTION CAUSED BY SECOND-GENERATION TYROSINE KINASE INHIBITORS IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA

EHA Library, Elena Tothova, 134730

ASSESSMENT OF THE MOLECULAR DISEASE LEVEL IN PATIENTS WITH BCR-ABL1 POSITIVE CML IN DENMARK AND ICELAND

EHA Library, Niels Pallisgaard, 134731

SAFETY AND EFFICACY OF PONATINIB IN REAL WORLD CLINICAL PRACTICE. RESULTS FROM THE SPANISH COMPASSIONATE USE PROGRAM. A GELMC STUDY

EHA Library, Valentin Garcia-Gutierrez, 134732

EARLY GOOD LATER BETTER. RELATIONSHIP OF BCR-ABL LEVEL AT 12 MONTHS OF TARGET THERAPY WITH INDIVIDUAL CHARACTERISTICS OF MOLECULAR RESPONSE IN EARLY TREATMENT PERIOD IN CHRONIC MYELOID LEUKEMIA

EHA Library, Aleksandr Fomin, 134733

EFFICACY OF GENERIC IMATINIB IN NEWLY DIAGNOSED CP-CML PATIENTS IN ESTONIAN POPULATION

EHA Library, Edward Laane, 134734

ROLE OF CHR AS A SURROGATE FOR MMR AT 12 AND 18 MONTHS IN RESOURCE CONSTRAINT SETTINGS: PATIENTS UNABLE TO AFFORD FREQUENT MOLECULAR MONITORING

EHA Library, Kamal Sahu, 134735

DEVELOPMENT OF INTERNATIONAL SCALE SECONDARY STANDARDS FOR BCR-ABL1 TRANSCRIPT QUANTITATIVE ASSAY

EHA Library, Gwo-Jen Day, 134736

LOW DOSE DASATINIB TREATMENT IN ELDERLY CML PATIENTS

EHA Library, Haruhiko Sano, 134737

A NATIONWIDE OBSERVATIONAL STUDY OF THE ISRAELI EXPERIENCE WITH PONATINIB OUTSIDE CLINICAL TRIALS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Adi Abulafia, 134738

ASSESSMENT OF PLATELET FUNCTIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Filiz Akbiyik, 134739

ELEVEN-YEAR RESULTS OF THE THERAPY OF CML TYROSINE KINASE INHIBITOR IN A LARGE INDUSTRIAL CENTER OF SIBERIA

EHA Library, Anna Lyamkina, 134740

CML AS PART OF DUAL MALIGNANCIES: POSSIBLE MECHANISMS AND REVIEW OF LITERATURE

EHA Library, Kamal Sahu, 134741

THE RESULTS OF TYROSINE-KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS ACCORDING TO 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA: RUSSIAN SINGLE-CENTER STUDY

EHA Library, Oleg Shukhov, 134742

OUT OF THE BAG ? FUNCTIONAL CHARACTERIZATION OF EX VIVO EXPANDED MSC

EHA Library, Sergio Lopes, 134743

FUNCTIONAL CAPACITY OF TUMOR LYSATE-PULSED MONOCYTE-DERIVED DENDRITIC CELLS INDUCING IN VITRO IMMUNE RESPONSES

EHA Library, Catarina Pinho, 134744

CELLULAR IMMUNOTHERAPY: A STORY OF HOPE

EHA Library, Ann VAN DE VELDE, 134745

MAGIC-TT-MEDIATED CELLS TARGET TRANSPLANTATION INTO BONE MARROW WHICH INCLUDES THE STUDY OF CELL DISTRIBUTION IN VIVO AND THE EFFECTS OF HEMATOPOIETIC RECONSTRUCTION.

EHA Library, Hao Huang, 134746

IMPLICATION OF THE PERCENTAGE OF MACROPHAGES WITH HAEMOPHAGOCYTOSIS IN THE DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Teresa Knight Asorey, 134747

BIOSIMILARS OF FILGRASTIM ? ZARZIO

EHA Library, Adrian Tempescul, 134748

THE ROLE OF ENDOTHELIAL CELL-EXPRESSED ?LPHA HEMOGLOBIN AND ITS MOLECULAR CHAPERONE AHSP IN BLOOD PRESSURE REGULATION

EHA Library, Christophe Lechauve, 134749

THE 'NORMOBARIC OXYGEN PARADOX': INFLUENCE OF NEW MODELS ON THE EVOLUTION OF ERYTHROPOIETIN, RETICULOCYTE COUNT AND HEMOGLOBIN CONCENTRATION IN PATIENTS UNDERGOING BREAST RECONSTRUCTION SURGERY.

EHA Library, Rossella Calabrese, 134750

THE RELATIONSHIP BETWEEN BONE MARROW STROMAL FIBROBLASTS, MYELOGRAM PERFORMANCE AND EFFICIENCY OF CHEMOTHERAPY IN CHILDREN WITH ACUTE LEUKEMIA

EHA Library, Katherine Bruslova, 134751

APHERESIS COLLECTION OF MOBILIZED HEMATOPOIETIC STEM CELLS FROM PERIPHERAL BLOOD IN HEALTY DONORS ? 15 YEARS OF EXPERIENCE

EHA Library, Rada Grubovikj Rastvorceva, 134752

PERFORMANCE EVALUATION OF Q-FLAG OF HEMATOLOGY ANALYZER, SYSMEX XN-20

EHA Library, Hye Ryoun Kim, 134753

SURVIVORSHIP PROGRAM: SECOND MALIGNANCIES IN LYMPHOMA SURVIVORS

EHA Library, Maria Pina Simula, 134754

GEMCITABIN, VINORELBINE AND PREDNISOLONE (GVP)

EHA Library, Semra Paydas, 134755

LYMPHADENOPATHY WITH ELEVATED IGG4 PLASMA CELLS IN CHILDHOOD: A POSSIBLE ASSOCIATION WITH MALIGNANCIES OR IMMUNE MEDIATED DISEASES

EHA Library, Maria Paola Boaro, 134756

LATE RELAPSE OF HODGKIN LYMPHOMA ? IS IT DIFFERENT IN CLINICAL CHARACTERISTICS AND OUTCOME?

EHA Library, Olivera Markovic, 134757

LYMPHOMA SURVIVORSHIP AND CARDIOVASCULAR DISEASES SURVEILLANCE

EHA Library, Maria Pina Simula, 134758

OSTEONECROSIS DETECTED BY WHOLE BODY MAGNETIC RESONANCE IN PATIENTS WITH HODGKIN LYMPHOMA TREATED BY BEACOPP

EHA Library, Caterina Patti, 134759

MORPHOLOGIC PATTERN AND PROGNOSTIC SIGNIFICANCE OF CD30 DISTRIBUTION WITHIN NEOPLASTIC CELLS IN HODGKIN LYMPHOMA.

EHA Library, Francesco Gaudio, 134760

EFFICACY AND SAFETY OF APREPITANT FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PEDIATRIC PATIENTS

EHA Library, Rosanna Parasole, 134761

TCL1A EXPRESSION IN SPLENIC MARGINAL ZONE LYMPHOMAS (SMZL) AND CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): CORELLATION WITH IMMUNOPHENOTYPE, MYD88L265P EXPRESSION AND CLINICAL DATA

EHA Library, Christina Kalpadakis, 134762

DESCRIPTION OF LATE ONSET NEUTROPENIA IN PATIENTS TREATED WITH BENDAMUSTINE PLUS RITUXIMAB

EHA Library, Benjamin Verriere, 134763

IS THERE A REAL INCRESED PREVALENCE OF HEPATITIS B REACTIVATION IN PATIENTS WITH CD20+ INDOLENT NON HODGKIN LYMPHOMA DURING MAINTENANCE WITH RITUXIMAB?

EHA Library, Orsola Vitagliano, 134764

THE ABSOLUTE LYMPHOCYTE COUNT AS INDEPENDENT PARAMETER MAY PREDICT PROGNOSIS OF FOLLICULAR LYMPHOMA PATIENTS

EHA Library, Jelena Jelicic, 134765

PEGFILGRASTIM IN PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING RITUXIMAB-BENDAMUSTINE TREATMENT IN INDOLENT NON HODGKIN LYMPHOMA : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 134766

RISK OF HISTOLOGIC TRANSFORMATION (HT) IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) PATIENTS TREATED WITH RITUXIMAB

EHA Library, Christina Kalpadakis, 134767

OUTCOMES OF INDOLENT LYMPHOMAS (INHL) IN THE ELDERLY - AN OBSERVATIONAL STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES

EHA Library, Dino Dujmovic, 134768

RESPONSE ASSESSMENT USING IWG2007 AND DEAUVILLE CRITERIA IN B-CELL NON-HODGKIN LYMPHOMA PATIENTS TREATED WITH 90Y-IT

EHA Library, Marcio Andrade-Campos, 134769

SHOULD STAGE I AND II FOLLICULAR LYMPHOMA BE TREATED EVEN IN THE RITUXIMAB ERA?

EHA Library, Dennisse Sharon Toral Ibarra, 134770

18FDG-PET ROLE OF IN THE EVALUATION OF BONE MARROW INFILTRATION IN PATIENTS WITH NHL

EHA Library, Fabio Trastulli, 134771

SUCCESSFUL SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS RITUXIMAB AT THE ULSTER HOSPITAL, BELFAST, NORTHERN IRELAND

EHA Library, Richard Dillon, 134772

THERAPY AND LONG-TERM RESULTS OF HEPATITIS C-ASSOCIATED INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, sergey lepkov, 134773

DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA (SLL)

EHA Library, Andrew J. Davies, 134774

INITIAL TREATMENT RESPONSE PREDICTS THE OUTCOME OF ELDERLY FOLLICULAR LYMPHOMA PATIENTS TREATED WITH IMMUNOCHEMOTHERAPY

EHA Library, Bosko Andjelic, 134775

DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL)

EHA Library, E Gyan, 134776

THE STRUCTURE AND EFFICACY OF B-CELL LYMPHOMA'S REAL LIFE TREATMENT ACCORDING DATA OF THE REGIONAL SEGMENT OF THE RUSSIAN FEDERATION'S FEDERAL REGISTER

EHA Library, Svetlana Volkova, 134777

DETECTION OF MYD88 (L265P) SOMATIC MUTATION IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL)

EHA Library, Christina Kalpadakis, 134778

SIGNIFICANT ROLE OF FLOW CYTOMETRY IN THE DIAGNOSIS AND FOLLOW UP OF GASTRIC LNH

EHA Library, Serena Luponio, 134779

RESULTS OF LAPAROSCOPIC SPLENECTOMY IN SPLENOMEGALY

EHA Library, Olga Soboleva, 134780

BRAF GENE MUTATIONS AND PROGNOSTIC SIGNIFICANCE OF CLINICAL FINDINGS IN CASTLEMAN DISEASE

EHA Library, Mehmet Türker, 134781

OCULAR ADNEXAL LYMPHOMAS: A CASE SERIES

EHA Library, Saniya Dhawan, 134782

RISK FACTORS AND MICROBIOLOGICAL FEATURES OF BLOODSTREAM NONTYPHOIDAL SALMONELLA INFECTION IN ADULT PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Po-Shen Ko, 134783

THE REAL WORLD USE OF BISPHOSPHONATES IN MULTIPLE MYELOMA AT UNIVERSITY COLLEGE HOSPITAL (UCH), LONDON: A COMPARISON WITH LATEST GUIDANCE

EHA Library, Oliver Cohen, 134784

ANTIFUNGAL PROPHYLAXIS WITH MICAFUNGIN IN PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENIC STEM CELL TRANSPLANTATION. A SINGLE CENTRE EXPERIENCE.

EHA Library, Alvaro Alba Sosa, 134785

THE POSITIVE IMPACT OF ANTIMICROBIAL STEWARDSHIP IN THE BIGGEST PEDIATRIC HAEMATOLOGY ONCOLOGY CENTRE, RUSSIA

EHA Library, Galina Solopova, 134786

INVESTIGATION OF RELATIONSHIP BETWEEN NEUTROPENIA AND SERUM CHITOTRIOSIDASE AND NEUTROPHIL GELATINASE RELATED LIPOCALIN ENZYME ACTIVITY IN CHILDREN UNDERGOING CHEMOTHERAPY

EHA Library, Orhan Gursel, 134787

EPIDEMIOLOGY OF FEBRILE EVENTS (FE) IN NEUTROPENIC PATIENTS (PTS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED BY

EHA Library, Vladimir Okhmat, 134788

THE CLINICAL SIGNIFICANCE OF PROCALCITONIN MONITORING IN INFECTED PATIENTS WITH HEMATOPATHY

EHA Library, Aining Sun, 134789